You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in API candesartan cilexetil


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing candesartan cilexetil

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Par Pharmaceutical Inc CANDESARTAN CILEXETIL candesartan cilexetil 49884-658 CARBOXYMETHYLCELLULOSE CALCIUM
Par Pharmaceutical Inc CANDESARTAN CILEXETIL candesartan cilexetil 49884-658 FERRIC OXIDE RED
Par Pharmaceutical Inc CANDESARTAN CILEXETIL candesartan cilexetil 49884-658 HYDROXYPROPYL CELLULOSE
Par Pharmaceutical Inc CANDESARTAN CILEXETIL candesartan cilexetil 49884-658 LACTOSE MONOHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing candesartan cilexetil

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc candesartan cilexetil 0378-3224 CARBOXYMETHYLCELLULOSE CALCIUM
Mylan Pharmaceuticals Inc candesartan cilexetil 0378-3224 GLYCERYL MONOSTEARATE
Mylan Pharmaceuticals Inc candesartan cilexetil 0378-3224 HYDROXYPROPYL CELLULOSE
Mylan Pharmaceuticals Inc candesartan cilexetil 0378-3224 LACTOSE MONOHYDRATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for candesartan cilexetil

Excipient focus: CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES

Excipient focus: CARBOXYMETHYLCELLULOSE CALCIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

candesartan cilexetil drug variants containing FERRIC OXIDE YELLOW

Company Ingredient NDC
Mylan Pharmaceuticals Inc candesartan cilexetil and hydrochlorothiazide 0378-3001
Macleods Pharmaceuticals Limited candesartan cilexetil and hydrochlorothiazide 33342-131
Physicians Total Care Inc candesartan cilexetil and hydrochlorothiazide 54868-4729
ANI Pharmaceuticals Inc candesartan cilexetil and hydrochlorothiazide 62559-650
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL MONO- AND DICAPRYLOCAPRATE

Excipient focus: GLYCERYL MONOSTEARATE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: PULLULAN

Excipient focus: STARCH, CORN

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links